Patent Assignment
Reel/Frame 037731/0875
Assignment of Security Interest
Recorded: 2016-02-05
Pages: 9
Assignor
THE BANK OF NOVA SCOTIA
Executed: 2005-12-08
Assignee
MDS INC.
100 INTERNATIONAL BOULEVARD, TORONTO, M9W6J6, CANADA
Covered Properties
(5)
Methods for the Selective Expansion of Lymphocytes by in Vitro Cultivation
Patent:
6,194,207 →
Application:
09/016,784 →
Hemoglobin-Polysaccharide Conjugates
The Efficient Culture of Stem Cells for the Production of Hemoglobin
Patent:
6,361,998 →
Application:
09/339,838 →
Methods for the Production of Tcr Gamma Delta T Cells
Patent:
6,537,812 →
Application:
09/807,987 →
Hemoglobin-Antioxidant Conjugates
Patent:
6,974,794 →
Application:
09/926,167 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
May 17, 2001
From: HEMOSOL INC.
To: MANUFACTURERS LIFE INSURANCE COMPANY, THE
Reel/Frame 012333/0801 →
Security Interest
Jan 16, 2002
From: HEMOSOL, INC.
To: MANUFACTURERS LIFE INSURANCE COMPANY, THE
Reel/Frame 012513/0043 →
Change of Name
Feb 27, 2008
From: 2140304 ONTARIO INC.
To: HEMOSOL BIOPHARMA INC.
Reel/Frame 020566/0895 →
Assignment of Assignor's Interest
Feb 27, 2008
From: HEMOSOL INC.
To: HEMOSOL LP
Reel/Frame 020566/0833 →
Assignment of Assignor's Interest
Feb 27, 2008
From: HEMOSOL LP
To: 2140304 ONTARIO INC.
Reel/Frame 020566/0874 →
Change of Name
Dec 30, 2008
From: HEMOSOL BIOPHARMA INC.
To: THERAPURE BIOPHARMA INC.
Reel/Frame 022034/0596 →
Assignment of Assignor's Interest
Dec 30, 2008
From: HEMOSOL INC.
To: HEMOSOL LP
Reel/Frame 022034/0401 →
Vesting Order
Dec 30, 2008
From: HEMOSOL LP
To: 2140304 ONTARIO INC.
Reel/Frame 022034/0536 →
Change of Name
Dec 30, 2008
From: 2140304 ONTARIO INC.
To: HEMOSOL BIOPHARMA INC.
Reel/Frame 022034/0592 →
Security Interest
Nov 23, 2015
From: THERAPURE BIOPHARMA INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037116/0471 →
Assignment of Security Interest
Feb 5, 2016
From: MDS INC.
To: CATALYST FUND LIMITED PARTNERSHIP II
Reel/Frame 037732/0097 →
Release of Security Interest
Feb 16, 2016
From: CATALYST FUND LIMITED PARTNERSHIP II
To: THERAPURE BIOPHARMA INC.
Reel/Frame 037743/0038 →